(Press-News.org) Thiazolidinediones (TZDs) are a class of drug that can be used to treat type 2 diabetes by reversing insulin resistance, one of the main hallmarks of the disease. While TZDs were extremely popular in the 1990’s and early 2000’s, they have fallen out of use among physicians in recent decades because they were discovered to cause unwanted side effects, including weight gain and excess fluid accumulation in body tissues.
Now, researchers at University of California San Diego School of Medicine are exploring how to isolate the positive effects of these drugs, which could help yield new treatments that don’t come with the old side effects. In a new study published in Nature Metabolism, the researchers discovered how one of the most well-known TZD drugs works at the molecular level and were able to replicate its positive effects in mice without giving them the drug itself.
“For decades, TZDs have been the only drugs we have that can reverse insulin resistance, but we seldom use them anymore because of their side effects profile,” said Jerrold Olefsky, M.D., a professor of medicine and assistant vice chancellor for integrative research at UC San Diego Health Sciences. “Impaired insulin sensitivity is the root cause of type 2 diabetes, so any treatment we can develop to safely restore this would be a major step forward for patients.”
The main driver of insulin resistance in type 2 diabetes is obesity, which currently affects more than 40 percent of Americans and in 2021 bore an annual medical cost of nearly $173 billion. In addition to causing adipose tissue (fat) to expand, obesity also causes low levels of inflammation. This inflammation causes immune cells, called macrophages, to accumulate in adipose tissue, where they can comprise up to 40 percent of the total number of cells in the tissue.
When adipose tissue is inflamed, these macrophages release tiny nanoparticles containing instructions for surrounding cells in the form of microRNAs, small fragments of genetic material that help regulate gene expression. These microRNA-containing capsules, called exosomes, are released into the circulation and can travel through the bloodstream to be absorbed by other tissues, such as the liver and muscles. This can then lead to the varied metabolic changes associated with obesity, including insulin resistance. For the current study, the researchers wanted to understand how TZD drugs, which restore insulin resistance, affect this exosome system.
The researchers treated a group of obese mice with rosiglitazone, a type of TZD drug. Those mice became more sensitive to insulin, but they also gained weight and retained excess fluid, known side effects of rosiglitazone. However, by isolating exosomes from the adipose tissue macrophages of the mice who had received the drug and injecting them into another group of obese mice that had not received it, the researchers were able to deliver the positive effects of rosiglitazone without transferring the negative effects.
“The exosomes were just as effective in reversing insulin resistance as the drug itself but without the same side effects,” said Olefsky. “This indicates that exosomes can ultimately link obesity-related inflammation and insulin resistance to diabetes. It also tells us that we may be able to leverage this system to boost insulin sensitivity.”
The researchers were also able to identify the specific microRNA within the exosomes that was responsible for the beneficial metabolic effects of rosiglitazone. This molecule, called miR-690, could eventually be leveraged into new therapies for type 2 diabetes.
“It’s likely not practical to develop exosomes themselves as a treatment because it would be difficult to produce and administer them, but learning what drives the beneficial effects of exosomes at the molecular level makes it possible to develop drugs that can mimic these effects,” said Olefsky. “There’s also plenty of precedent for using microRNAs themselves as drugs, so that’s the possibility we’re most excited about exploring for miR-690 going forward.”
Link to full study: https://www.nature.com/articles/s42255-024-01023-w
Additional authors on the study include: Theresa V. Rohm, Felipe Castellani Gomes Dos Reis, Roi Isaac, Cairo Murphy, Karina Cunha e Rocha, Gautam Bandyopadhyay, Hong Gao, Avraham M. Libster, Rizaldy C. Zapata, Yun Sok Lee, Wei Ying, Charlene Miciano and Allen Wang, all at UC San Diego.
This study was funded, in part, by the National Institutes of Health (grants P30DK063491, R01DK101395, DK124298, R00DK115998, R21HD107516, R01DK125560, DK099205, AA028550, DK101737, AA011999, DK120515, AA029019, DK091183), the Swiss National Science Foundation (grant P2BSP3_200177), the Larry L. Hillblom Foundation (grants 2023-D-012-FEL and 2023-D-011-FEL), UCLA LIFT-UP, and Janssen Pharmaceuticals.
# # #
END
This outdated diabetes drug still has something to offer
By learning how an old diabetes drug works, researchers are discovering new, safer treatment options
2024-04-11
ELSE PRESS RELEASES FROM THIS DATE:
Developing best practices for human-AI collaboration in engineering design
2024-04-11
As artificial intelligence is inevitably woven into the workplace, teams of humans will increasingly collaborate with robots on complex design problems, such as those in the auto, aviation, and space industries.
“Right now, design is mainly done by humans, and it’s based on their expertise and intuitive decision-making, which is learned over time,” says A. Emrah Bayrak, an assistant professor of mechanical engineering and mechanics in Lehigh University’s P.C. Rossin College of Engineering and Applied Science. “Usually, ...
Novel CT exam reduces need for invasive artery treatment
2024-04-11
OAK BROOK, Ill. – A new study showed that a non-invasive imaging test can help identify patients with coronary artery blockage or narrowing who need a revascularization procedure. The findings were published as a Special Report in Radiology: Cardiothoracic Imaging, a journal of the Radiological Society of North America (RSNA).
Doctors use coronary CT angiography (CTA) to diagnose narrowed or blocked arteries in the heart. A CTA exam receives a score from mild (0-1) to moderate (2-3) to severe (4-5). Patients ...
ERC Advanced Grant: 2.5 million euros for Tobias Brixner
2024-04-11
Many people are familiar with the principle of electronic excitation from their physics lessons: electrons in atoms or molecules absorb energy, typically from light, and rise to a higher energy level. This can have various consequences – in photovoltaic technology, the phenomenon ensures that electricity can be generated from sunlight.
Measuring electronic excitation according to scientific standards and investigating how excited electrons influence each other is a real challenge: “Electronic excitation and the subsequent processes take place extremely quickly, many things happen simultaneously“, explains Tobias Brixner, Chair of Physical Chemistry ...
Proud seafarers have strong doubts about the safety of autonomous ships
2024-04-11
The maritime profession is among the world’s oldest professions, and today’s shipping is based on long and proud traditions. Professional pride and commitment are often deeply ingrained in seafarers, and for many, the job is more of a way of life. New technologies will bring about major changes in the work of bridge officers, who have the ultimate responsibility on board Norwegian vessels.
Strong doubts about safety
“Bridge officers rely on automated systems that are already found on board, such as advanced autopilot systems. However, there is strong scepticism, almost mistrust, that increased automation and autonomous ...
People who use willpower alone to achieve goals, resist temptation, deemed more trustworthy
2024-04-11
People who use willpower to overcome temptations and achieve their goals are perceived as more trustworthy than those who use strategies that involve external incentives or deterrents – such as swear jars or internet-blocking apps – according to research published by the American Psychological Association.
“The knowledge that people can use external commitment strategies to overcome self-control problems has existed in some form for thousands of years. Since at least the time of Homer and Odysseus, the focus has primarily been on the efficacy of these strategies for the person choosing to engage ...
New study shows effect of socio-economic factors—housing, food, neighborhood—to predict diabetic patients’ risk of heart failure
2024-04-11
CLEVELAND—A recent study by Case Western Reserve University used national data from U.S. military veterans with diabetes to validate and modify a widely accepted model used to predict the risk of heart failure in diabetic patients.
The model, called the WATCH-DM score, is used to predict the likelihood of heart failure in diabetes patients within five years.
But because it overlooks the influence of social determinants of health‚ such as housing, food and a patient’s neighborhood, the researchers used a social deprivation index (SDI), a multi-component summary score, to adjust the WATCH-DM score.
The SDI, introduced by the Robert ...
Mapped: 33 new big game migrations across American West
2024-04-11
RESTON, Va. — A new set of maps that document the movements of ungulates was published today in the fourth volume of the Ungulate Migrations of the Western United States. The maps in this collaborative U.S. Geological Survey report series reveal the migration routes and critical ranges used by ungulates, or hooved mammals, in the western U.S., furthering scientists’ understanding of the geography of big game migrations.
The new volume, “Ungulate Migrations of the Western United States: Volume 4,” documents 33 mule deer, ...
Can we crack the code of cartilage?
2024-04-11
Can Jos Malda crack the code of cartilage?
In our aging society, healing joint problems is becoming increasingly important. To do this, cartilage damage must become repairable. But so far it has proven impossible to recreate the intricate internal structure of cartilage. Professor Jos Malda has now received an ERC Advanced grant of €2.5 million to crack that code.
Bringing biology and technology together
Throughout his career, Jos Malda has been concerned with the interface between biology and technology. It took him from studying Bioprocess Engineering in Wageningen to ...
Moments of clarity in the fog of dementia
2024-04-11
A recent Mayo Clinic study published in Alzheimer's & Dementia: The Journal of the Alzheimer's Association investigated lucid episodes in people living with later stages of dementia, providing insights into how these occurrences reveal themselves.
The findings showed that 75% of people having lucid episodes were reported to have Alzheimer’s Disease as opposed to other forms of dementia.
Researchers define lucid episodes as unexpected, spontaneous, meaningful and relevant communication from a ...
Heart transplant recipient discovers a calling for advocacy, support for others
2024-04-11
11 April, Prague, Czech Republic—Glen Kelley’s journey as a heart transplant recipient came full circle today in Prague, as he addressed attendees of the Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation (ISHLT), including members of his own care teams.
As a high school senior outside of Peoria, Illinois, Kelley was diagnosed with stage-4 Hodgkin’s lymphoma and underwent eight months of chemotherapy and radiation. After 10 months in remission, the ...
LAST 30 PRESS RELEASES:
Family ties and firm performance: How cousin marriage traditions shape informal businesses in Africa
Novel flu vaccine adjuvant improves protection against influenza viruses, study finds
Manipulation of light at the nanoscale helps advance biosensing
New mechanism discovered in ovarian cancer peritoneal metastasis: YWHAB restriction drives stemness and chemoresistance
New study links blood metabolites and immune cells to increased risk of urolithiasis
Pyruvate identified as a promising therapeutic agent for ulcerative colitis by targeting cytosolic phospholipase A2
New insights into the clinical impact of IKBKG mutations: Understanding the mechanisms behind rare immunodeficiency syndromes
Displays, imaging and sensing: New blue fluorophore breaks efficiency records in both solids and solutions
Sugar, the hidden thermostat in plants
Personality can explain why some CEOs earn higher salaries
This puzzle game shows kids how they’re smarter than AI
Study suggests remembrances of dead played role in rise of architecture in Andean region
Brain stimulation can boost math learning in people with weaker neural connections
Inhibiting enzyme could halt cell death in Parkinson’s disease, study finds
Neurotechnology reverses biological disadvantage in maths learning
UNDER EMBARGO: Neurotechnology reverses biological disadvantage in maths learning
Scientists target ‘molecular machine’ in the war against antimicrobial resistance
Extending classical CNOP method for deep-learning atmospheric and oceanic forecasting
Aston University research: Parents should encourage structure and independence around food to support children’s healthy eating
Thunderstorms are a major driver of tree death in tropical forests
Danforth Plant Science Center adds two new faculty members
Robotic eyes mimic human vision for superfast response to extreme lighting
Racial inequities and access to COVID-19 treatment
Residential segregation and lung cancer risk in African American adults
Scientists wipe out aggressive brain cancer tumors by targeting cellular ‘motors’
Capturability distinction analysis of continuous and pulsed guidance laws
CHEST expands Bridging Specialties Initiative to include NTM disease and bronchiectasis on World Bronchiectasis Day
Exposure to air pollution may cause heart damage
SwRI, UTSA selected by NASA to test electrolyzer technology aboard parabolic flight
Prebiotics might be a factor in preventing or treating issues caused by low brain GABA
[Press-News.org] This outdated diabetes drug still has something to offerBy learning how an old diabetes drug works, researchers are discovering new, safer treatment options